Earnings History Data for Capricor Therapeutics, Inc. (CAPR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
07-08-2024 AH CAPR Capricor Therapeutics, Inc. 123.75 -0.35 -0.31 -0.29 Capricor Therapeutics GAAP EPS of -$0.35 beats by $0.01, revenue of $3.97M beats by $0.31M
[8/7/2024 4:17 PM]
3.83 0.27 
(7.72%)
3.95 0.39 
(10.96%)
2.68 - 8.22 720,115 360,000 4,231
13-05-2024 AH CAPR Capricor Therapeutics, Inc. 170.19 -0.31 -0.11 -0.31 Capricor Therapeutics GAAP EPS of -$0.31 misses by $0.20, revenue of $4.91M misses by $4.79M
[5/13/2024 4:13 PM]
5.22 -0.22 
(-3.95%)
5.06 -0.38 
(-6.99%)
2.68 - 8.22 625,964 210,000 20,471
29-02-2024 AH CAPR Capricor Therapeutics, Inc. 121.94 -0.02 -0.23 -0.31 Capricor Therapeutics GAAP EPS of -$0.02 beats by $0.18, revenue of $12.08M beats by $1.48M
[2/29/2024 4:16 PM]
4.57 0.37 
(8.81%)
4.49 0.29 
(6.90%)
2.68 - 8.22 353,575 190,000 7,692
14-11-2023 AH CAPR Capricor Therapeutics, Inc. 72.18 -0.25 -0.27 -0.26 Capricor Therapeutics GAAP EPS of -$0.25 beats by $0.05, revenue of $6.19M beats by $3.02M
[11/14/2023 4:08 PM]
3.19 0.19 
(6.15%)
3.01 0.0 
(0.00%)
2.68 - 8.22 225,280 200,000 7,595
07-08-2023 AH CAPR Capricor Therapeutics, Inc. 112.20 -0.29 -0.34 -0.29 Capricor Therapeutics GAAP EPS of -$0.29 beats by $0.06, revenue of $3.92M beats by $2.32M
[8/7/2023 4:32 PM]
5.71 1.00 
(21.23%)
5.00 0.29 
(6.16%)
3.30 - 6.58 315,313 40,000 901
11-05-2023 AH 4:00 PM ET
(May 11)
CAPR Capricor Therapeutics, Inc. 101.84 -0.31 -0.32 -0.32 Capricor Therapeutics GAAP EPS of -$0.31 beats by $0.01, revenue of $2.98M beats by $2.48M
[5/11/2023 4:03 PM]
4.06 -0.05 
(-1.22%)
4.20 0.09 
(2.24%)
2.81 - 6.58 61,431 50,000 642
15-03-2023 AH 4:00 PM ET
(Mar 15)
CAPR Capricor Therapeutics, Inc. 108.54 -0.31 0.00 -0.26 Capricor Therapeutics GAAP EPS of -$0.31 beats by $0.03, revenue of $0.96M beats by $0.96M
[3/15/2023 4:03 PM]
4.52 0.05 
(1.12%)
4.64 0.17 
(3.80%)
2.81 - 6.58 135,016 90,000 1,122
10-11-2022 AH 4:05 PM ET
(Nov 10)
CAPR Capricor Therapeutics, Inc. 119.05 -0.26 -0.28 -0.17 Capricor Therapeutics GAAP EPS of -$0.26 beats by $0.05, revenue of $1.59M beats by $1.45M
[11/10/2022 4:03 PM]
4.55 -0.35 
(-7.14%)
4.90 0.0 
(0.00%)
2.56 - 6.58 200,402 140,000 175
10-08-2022 AH 4:00 PM ET
(Aug 10)
CAPR Capricor Therapeutics, Inc. 108.00 -0.29 -0.25 -0.21 Capricor Therapeutics GAAP EPS of -$0.29 misses by $0.03
[8/10/2022 4:14 PM]
5.30 0.78 
(17.26%)
4.70 0.18 
(3.98%)
2.56 - 5.85 546,716 100,000 12,816
10-05-2022 AH 4:00 PM ET
(May 10)
CAPR Capricor Therapeutics, Inc. 84.89 -0.32 0.00 -0.23 Capricor Therapeutics GAAP EPS of -$0.32
[5/10/2022 4:06 PM]
2.91 -0.32 
(-9.95%)
3.18 0.06 
(1.92%)
2.56 - 6.22 107,902 90,000 120
10-03-2022 AH 4:05 PM ET
(Mar 10)
CAPR Capricor Therapeutics, Inc. 106.98 -0.26 -0.19 -0.21 4.22 0.10 
(2.43%)
4.24 0.12 
(2.91%)
2.56 - 6.22 166,951 180,000 4,058
09-11-2021 AH 4:00 PM ET
(Nov 9)
CAPR Capricor Therapeutics, Inc. 87.71 -0.17 -0.22 -0.20 Capricor Therapeutics EPS beats by $0.06
[11/9/2021 4:09 PM]
3.50 -0.12 
(-3.31%)
3.62 0.0 
(0.00%)
3.13 - 8.40 257,395 160,000 4,734
12-08-2021 AH 4:05 PM ET
(Aug 12)
CAPR Capricor Therapeutics, Inc. 102.04 -0.21 -0.23 -0.23 Capricor Therapeutics EPS beats by $0.02, misses on revenue
[8/12/2021 4:13 PM]
4.03 -0.44 
(-9.93%)
4.08 -0.40 
(-8.93%)
3.13 - 8.40 411,531 110,000 32,880
13-05-2021 AH 4:00 PM ET
(May 13)
CAPR Capricor Therapeutics, Inc. 80.48 -0.23 0.00 -0.30 Capricor Therapeutics reports Q1 results
[5/13/2021 4:21 PM]
3.64 0.48 
(15.19%)
3.35 0.19 
(6.01%)
3.13 - 12.32 620,944 520,000 2,699
11-03-2021 AH 4:00 PM ET
(Mar 11)
CAPR Capricor Therapeutics, Inc. 105.30 -0.21 0.00 -0.34 Capricor Therapeutics EPS misses by $0.01
[3/11/2021 4:04 PM]
5.18 -0.36 
(-6.59%)
4.88 -0.66 
(-11.91%)
0.88 - 12.32 504,669 423,807 22,425
12-11-2020 AH 4:00 PM ET
(Nov 12)
CAPR Capricor Therapeutics, Inc. 83.43 -0.20 0.00 -0.43 Capricor Therapeutics reports Q3 results
[11/12/2020 4:07 PM]
4.34 -0.30 
(-6.56%)
4.22 -0.43 
(-9.25%)
0.88 - 12.32 400,311 711,590 6,045
06-08-2020 AH 4:00 PM ET
(Aug 6)
CAPR Capricor Therapeutics, Inc. 109.55 -0.23 -0.37 -0.59 Capricor Therapeutics EPS beats by $0.11
[8/6/2020 4:05 PM]
6.48 -1.42 
(-17.97%)
6.49 -1.41 
(-17.85%)
0.88 - 12.32 3,732,419 8,324,786 215,305